113 related articles for article (PubMed ID: 8137875)
81. The novel δ opioid receptor agonist KNT-127 produces antidepressant-like and antinociceptive effects in mice without producing convulsions.
Saitoh A; Sugiyama A; Nemoto T; Fujii H; Wada K; Oka J; Nagase H; Yamada M
Behav Brain Res; 2011 Oct; 223(2):271-9. PubMed ID: 21565223
[TBL] [Abstract][Full Text] [Related]
82. Blockade of the antinociceptive activity of centrally administered ketorolac by nor-binaltorphimine.
Tripathi A; Welch SP
Eur J Pharmacol; 1995 May; 278(1):27-32. PubMed ID: 7664811
[TBL] [Abstract][Full Text] [Related]
83. Modulation of mu-mediated antinociception by delta agonists: characterization with antagonists.
Heyman JS; Jiang Q; Rothman RB; Mosberg HI; Porreca F
Eur J Pharmacol; 1989 Oct; 169(1):43-52. PubMed ID: 2557223
[TBL] [Abstract][Full Text] [Related]
84. Algogenic mediator-induced nociceptive response in diabetic mice.
Kamei J; Kashiwazaki T; Taki K; Hitosugi H; Nagase H
Eur J Pharmacol; 1999 Mar; 369(3):319-23. PubMed ID: 10225369
[TBL] [Abstract][Full Text] [Related]
85. Profiles of the antinociceptive effect of R-84760, a selective kappa-opioid receptor agonist, in the formalin test in mice.
Fujibayashi K; Iizuka Y
Jpn J Pharmacol; 1995 May; 68(1):57-63. PubMed ID: 7494383
[TBL] [Abstract][Full Text] [Related]
86. The Opioid Interactions of the Antipsychotic Medications Risperidone and Amisulpride in Mice and Their Potential Use in the Treatment of Other Non-Psychotic Medical Conditions.
Schreiber S; Pick CG
Cell Mol Neurobiol; 2021 Jul; 41(5):1077-1084. PubMed ID: 33184770
[TBL] [Abstract][Full Text] [Related]
87. Pharmacological study on the novel antinociceptive agent, a novel monoterpene alkaloid from Incarvillea sinensis.
Chi YM; Nakamura M; Yoshizawa T; Zhao XY; Yan WM; Hashimoto F; Kinjo J; Nohara T; Sakurada S
Biol Pharm Bull; 2005 Oct; 28(10):1989-91. PubMed ID: 16204962
[TBL] [Abstract][Full Text] [Related]
88. Antinociceptive effect of Gosha-jinki-gan, a Kampo medicine, in streptozotocin-induced diabetic mice.
Suzuki Y; Goto K; Ishige A; Komatsu Y; Kamei J
Jpn J Pharmacol; 1999 Feb; 79(2):169-75. PubMed ID: 10202852
[TBL] [Abstract][Full Text] [Related]
89. The effects of cyclosporine on morphine-induced antinociception in diabetic mice.
Kamei J; Kawashima N; Suzuki T; Misawa M; Kasuya Y
Neurosci Lett; 1993 Aug; 158(2):213-6. PubMed ID: 8233098
[TBL] [Abstract][Full Text] [Related]
90. Intrathecal administration of p-hydroxymercuribenzoate or phosphoramidon/bestatin-combined induces antinociceptive effects through different opioid mechanisms.
Tan-No K; Taira A; Inoue M; Ohshima K; Sakurada T; Sakurada C; Nylander I; Demuth HU; Silberring J; Terenius L; Tadano T; Kisara K
Neuropeptides; 1998 Oct; 32(5):411-5. PubMed ID: 9845000
[TBL] [Abstract][Full Text] [Related]
91. Role of cholecystokinin in the reduction of endomorphin-2-induced antinociception in diabetic mice.
Kamei J; Zushida K; Nagase H
Eur J Pharmacol; 2001 Mar; 416(1-2):95-9. PubMed ID: 11282117
[TBL] [Abstract][Full Text] [Related]
92. Central pharmacological activity of a quaternary ammonium compound in streptozotocin diabetic mice.
Quock RM; Ishii MM; Emmanouil DE
Life Sci; 1988; 43(17):1411-7. PubMed ID: 2846978
[TBL] [Abstract][Full Text] [Related]
93. Characterization of the analgesic properties of nomifensine in rats.
Gilbert AK; Franklin KB
Pharmacol Biochem Behav; 2001 Apr; 68(4):783-7. PubMed ID: 11526977
[TBL] [Abstract][Full Text] [Related]
94. Mechanistic analysis of high antitumor effect of intradermal administration of lipopolysaccharide from Pantoea Agglomerans.
Iwamoto I; Goto S; Kera J; Soma G; Takeuchi S; Nagata Y
Med Oncol; 1996 Jun; 13(2):103-9. PubMed ID: 9013473
[TBL] [Abstract][Full Text] [Related]
95. Effect of mexiletine on fenvalerate-induced nociceptive response in diabetic mice.
Kamei J; Saitoh A; Tamura N
J Pharmacol Sci; 2004 Nov; 96(3):280-5. PubMed ID: 15528843
[TBL] [Abstract][Full Text] [Related]
96. Antinociceptive effect of vitamin K2 (menatetrenone) in diabetic mice.
Onodera K; Zushida K; Kamei J
Jpn J Pharmacol; 2001 Mar; 85(3):335-7. PubMed ID: 11325029
[TBL] [Abstract][Full Text] [Related]
97. Tail pinch behavior and analgesia in diabetic mice.
Levine AS; Morley JE; Wilcox G; Brown DM; Handwerger BS
Physiol Behav; 1982 Jan; 28(1):39-43. PubMed ID: 7079321
[TBL] [Abstract][Full Text] [Related]
98. Pantoea agglomerans lipopolysaccharide maintains bone density in premenopausal women: a randomized, double-blind, placebo-controlled trial.
Nakata K; Nakata Y; Inagawa H; Nakamoto T; Yoshimura H; Soma G
Food Sci Nutr; 2014 Nov; 2(6):638-46. PubMed ID: 25493180
[TBL] [Abstract][Full Text] [Related]
99. Useful Cases of Patients With Developmental Disorders Improved by Oral Administration of LPS Derived from
Morishima A; Zhang R; Nagaoka T; Inagawa H
Anticancer Res; 2020 Aug; 40(8):4755-4762. PubMed ID: 32727802
[TBL] [Abstract][Full Text] [Related]
100. Inhibition of NLRP3 Inflammasome Prevents LPS-Induced Inflammatory Hyperalgesia in Mice: Contribution of NF-κB, Caspase-1/11, ASC, NOX, and NOS Isoforms.
Dolunay A; Senol SP; Temiz-Resitoglu M; Guden DS; Sari AN; Sahan-Firat S; Tunctan B
Inflammation; 2017 Apr; 40(2):366-386. PubMed ID: 27924425
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
